
UK-based pharmaceutical and biotechnology company GSK has reached a settlement with a US man who claims the drugmaker’s heartburn medicine …

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …

